Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magali Svrcek

Showing results (111-120 of 163) with videos related to

Pageof 17
Sort By:
Oncogenesis|September 20, 2018
Targeting nonsense-mediated mRNA decay in colorectal cancers with microsatellite instabilityA'dem Bokhari, Vincent Jonchere, Anaïs Lagrange, et al.
Free Radical Research|March 13, 2025
SOD mimics delivered to the gut using lactic acid bacteria mitigate the colitis symptoms in a mouse model of inflammatory bowel diseasesGabrielle Schanne, Amandine Vincent, Florian Chain, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 29, 2025
FOLFIRINOX or FOLFOX for locally advanced or metastatic small bowel adenocarcinoma: PRODIGE 86 - FFCD-GONO - ENGIC 02 - FOLFIRINOX SBA phase II randomized trialThomas Aparicio, Anthony Turpin, Aziz Zaanan, et al.
Cellular and Molecular Life Sciences : CMLS|September 26, 2012
Extensive characterization of sphere models established from colorectal cancer cell linesAda Collura, Laetitia Marisa, Diletta Trojan, et al.
Gut|October 16, 2010
Methylation tolerance due to an O6-methylguanine DNA methyltransferase (MGMT) field defect in the colonic mucosa: an initiating step in the development of mismatch repair-deficient colorectal cancersMagali Svrcek, Olivier Buhard, Chrystelle Colas, et al.
European Journal of Cancer (Oxford, England : 1990)|June 4, 2013
S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinomaJean-Baptiste Bachet, Raphael Maréchal, Pieter Demetter, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 15, 2016
Macroscopy predicts tumor progression in gastric cancer: A retrospective patho-historical analysis based on Napoleon Bonaparte's autopsy reportHeather Dawson, Alexander Novotny, Karen Becker, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 21, 2023
Multicenter Harmonization Study of Pan-Trk Immunohistochemistry for the Detection of NTRK3 FusionsJulien Adam, Nolwenn Le Stang, Arnaud Uguen, et al.
Histopathology|January 29, 2021
Histopathological diagnosis of tumour deposits in colorectal cancer: a Delphi consensus studyAmy Lord, Gina Brown, Muti Abulafi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 6, 2018
Clinical implications of CTNNA1 germline mutations in asymptomatic carriersPatrick R Benusiglio, Chrystelle Colas, Erell Guillerm, et al.
Pageof 17

Showing results (111-120 of 163) with videos related to

Sort By:
Pageof 17
Oncogenesis|September 20, 2018
Targeting nonsense-mediated mRNA decay in colorectal cancers with microsatellite instabilityA'dem Bokhari, Vincent Jonchere, Anaïs Lagrange, et al.
Free Radical Research|March 13, 2025
SOD mimics delivered to the gut using lactic acid bacteria mitigate the colitis symptoms in a mouse model of inflammatory bowel diseasesGabrielle Schanne, Amandine Vincent, Florian Chain, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 29, 2025
FOLFIRINOX or FOLFOX for locally advanced or metastatic small bowel adenocarcinoma: PRODIGE 86 - FFCD-GONO - ENGIC 02 - FOLFIRINOX SBA phase II randomized trialThomas Aparicio, Anthony Turpin, Aziz Zaanan, et al.
Cellular and Molecular Life Sciences : CMLS|September 26, 2012
Extensive characterization of sphere models established from colorectal cancer cell linesAda Collura, Laetitia Marisa, Diletta Trojan, et al.
Gut|October 16, 2010
Methylation tolerance due to an O6-methylguanine DNA methyltransferase (MGMT) field defect in the colonic mucosa: an initiating step in the development of mismatch repair-deficient colorectal cancersMagali Svrcek, Olivier Buhard, Chrystelle Colas, et al.
European Journal of Cancer (Oxford, England : 1990)|June 4, 2013
S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinomaJean-Baptiste Bachet, Raphael Maréchal, Pieter Demetter, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 15, 2016
Macroscopy predicts tumor progression in gastric cancer: A retrospective patho-historical analysis based on Napoleon Bonaparte's autopsy reportHeather Dawson, Alexander Novotny, Karen Becker, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 21, 2023
Multicenter Harmonization Study of Pan-Trk Immunohistochemistry for the Detection of NTRK3 FusionsJulien Adam, Nolwenn Le Stang, Arnaud Uguen, et al.
Histopathology|January 29, 2021
Histopathological diagnosis of tumour deposits in colorectal cancer: a Delphi consensus studyAmy Lord, Gina Brown, Muti Abulafi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 6, 2018
Clinical implications of CTNNA1 germline mutations in asymptomatic carriersPatrick R Benusiglio, Chrystelle Colas, Erell Guillerm, et al.
Pageof 17